Self-Assembling Peptides for Sterilizable Hydrogel Scaffolds
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current peptide-based materials for medical and research applications face challenges in self-assembly, sterilization, and biocompatibility, particularly in forming stable hydrogel scaffolds with non-cytotoxic and biodegradable properties.
Innovation Solution
Self-assembling peptides composed of non-ionic, polar amino acids, such as serine and threonine, which form hydrogels under physiological conditions, and can be sterilized using autoclaving without significant degradation, providing a stable and biocompatible scaffold for medical applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional peptide-based materials are used for self-assembly, then hydrogel scaffold formation is achieved, but sterilization causes significant degradation and loss of structural integrity
Solution Approach 1:
The patent modifies the amino acid composition parameters by incorporating non-ionic polar amino acids (serine, threonine) alongside hydrophobic amino acids. This compositional parameter change enables the peptide to withstand sterilization conditions without degradation, as the non-ionic polar residues provide structural stability during autoclaving while maintaining self-assembly capability.
Solution Approach 2:
The patent creates a composite peptide structure combining different amino acid types with complementary properties: hydrophobic amino acids drive self-assembly and membrane formation, while non-ionic polar amino acids provide sterilization resistance. This composite approach at the molecular level resolves the contradiction between sterilization stability and structural integrity.
2Stability of the object's composition
If peptides with high self-assembly capability are used, then stable hydrogel scaffolds are formed, but cytotoxicity increases
Solution Approach 1:
The patent adjusts the amino acid composition parameters by incorporating non-toxic non-ionic polar amino acids (serine, threonine) that modify the peptide's interaction with cellular components. This compositional change reduces cytotoxicity while the overall peptide structure maintains self-assembly capability for stable hydrogel formation.
Solution Approach 2:
The patent applies local quality by positioning specific amino acid residues at different locations within the peptide structure. Hydrophobic residues are positioned to drive self-assembly and membrane formation, while non-ionic polar residues are positioned to interact with the aqueous environment and cell membranes in a non-toxic manner, enabling localized optimization of both stability and biocompatibility.
3Speed
If peptides are designed for rapid self-assembly, then quick hydrogel formation is achieved, but control over assembly morphology is reduced
Solution Approach 1:
The patent modifies the self-assembly parameters by changing the amino acid sequence composition and stoichiometry. The specific ratio and arrangement of hydrophobic and non-ionic polar amino acids create optimal intermolecular interaction parameters that enable rapid nucleation and growth while maintaining control over the final nanofiber and hydrogel morphology.
Solution Approach 2:
The patent employs dynamic control of self-assembly by designing peptides that can adjust their conformation and interaction strength in response to environmental conditions. The non-ionic polar amino acids provide dynamic hydrogen bonding capabilities that allow rapid initial assembly followed by controlled structural refinement, achieving both speed and morphology control.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The peptides effectively form stable hydrogel scaffolds with enhanced storage modulus and biocompatibility, supporting cell viability and allowing for the gradual release of biologically active agents, while maintaining stability and sterility, thus addressing the limitations of existing peptide materials.
Implementation Method 1
Self-assembling peptides composed of non-ionic, polar amino acids, such as serine and threonine, which form hydrogels under physiological conditions
Implementation Method 2
treating the peptide solution at a predetermined temperature and a predetermined pressure for a predetermined period of time to sterilize the peptide solution, the predetermined temperature and predetermined pressure selected to provide conditions of saturated steam
Data Source
AI summary
Compositions, peptide solutions and macroscopic scaffolds of self-assembling peptides consisting essentially of non-ionic, polar amino acids are provided. Particular peptides include those comprising, or consisting essentially of, serine, threonine, tyrosine, cysteine, glutamine, asparagine, methionine, tryptophan, hydroxy-proline, and combinations thereof. Methods of sterilizing the self-assembling peptides, and scaffolds comprising the peptides are also provided.